A molecular trio in relapse and remission in multiple sclerosis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Energy Engineering and Power Technology,Fuel Technology
Link
http://www.nature.com/articles/nri2548.pdf
Reference48 articles.
1. Steinman L. Multiple sclerosis: a two stage disease. Nature Immunol. 2, 762–765 (2001).
2. Steinman, L., Martin, R., Bernard, C., Conlon, P. & Oksenberg, J. R. Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy. Annu. Rev. Neurosci. 25, 491–505 (2002).
3. Chabas, D. et al. The influence of the pro-inflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 294, 1731–1735 (2001).
4. Ashkar, S. et al. Eta-1 (osteopontin): an early component of type 1 (cell-mediated) immunity. Science 287, 860–864 (2000).
5. Yednock, T. et al. Prevention of experimental autoimmune encephalomyelitis by antibodies against α4β1 integrin. Nature 356, 63–66 (1992). This paper describes the history of the development of natalizumab for the treatment of relapsing-remitting multiple sclerosis.
Cited by 169 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The role of genetics and gender specific differences in neurodegenerative disorders: Insights from molecular and immune landscape;Journal of Neuroimmunology;2023-11
2. Associations of cortical SPP1 and ITGAX with cognition and common neuropathologies in older adults;Alzheimer's & Dementia;2023-09-19
3. A Dual Role of Osteopontin in Modifying B Cell Responses;Biomedicines;2023-07-12
4. Gateway reflexes are neural circuits that establish the gateway of immune cells to regulate tissue specific inflammation;Expert Opinion on Therapeutic Targets;2023-06-03
5. GM-CSF Promotes the Survival of Peripheral-Derived Myeloid Cells in the Central Nervous System for Pain-Induced Relapse of Neuroinflammation;The Journal of Immunology;2023-05-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3